Calibrated ensemble deep learning for four-class lung CT image classification and uncertainty-based referral - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Uncertainty-Guided Referral Using Calibrated Deep-Learning Ensembles for Four-Class Lung CT Classification

  • By

  • Mohammad Fathi

  • Mohammad Reza Gholami

  • Nima Alipour

  • Mahshad Faramarzi

  • Niloofar Deravi

  • Danyal Yarahmadi

  • October 9, 2026

Share

Clinical Scorecard: Uncertainty-Guided Referral Using Calibrated Deep-Learning Ensembles for Four-Class Lung CT Classification

At a Glance

CategoryDetail
ConditionClinical topic addressed by the source article: Uncertainty-Guided Referral Using Calibrated Deep-Learning Ensembles for Four-Class Lung CT Classification
Key MechanismsMechanisms or clinical associations described in the source article.
Target PopulationPatients or participants described in the source article.
Care SettingRetrospective methodological evaluation of an assistive image-classification approach; the stated intended use is not to substitute for radiologist interpretation or definitive diagnostic assessment.

Key Highlights

  • The study developed and internally evaluated an ensemble for four-class, image-level chest CT classification.
  • The analysis assessed validation-based model selection, weighted ensembling, temperature scaling, and class-specific decision scaling.
  • The study examined class-specific errors, probability calibration, and predictive entropy as an indicator of misclassification.
  • The study assessed uncertainty-based referral and compared cancer-versus-normal discrimination with discrimination among malignant subtypes.
  • The dataset was a publicly available collection of images distributed as JPG or PNG files rather than original DICOM studies.

Guideline-Based Recommendations

Diagnosis

  • The study classifies CT images into adenocarcinoma, large cell carcinoma, squamous cell carcinoma, or normal lung.
  • The stated intended use is assistive classification, not substitution for histopathology, immunohistochemistry, molecular testing, or radiologist interpretation.

Management

  • The study evaluates uncertainty-informed prioritization for expert review; it does not evaluate treatment or provide treatment recommendations.

Monitoring & Follow-up

  • The study assesses discrimination, calibration, class-specific errors, and predictive entropy.

Risks

    Patient & Prescribing Data

    No patient-level demographic or clinical characteristics were reported. The dataset comprised 1,000 images across four repository labels, and the number of unique patients or examinations was unknown.

    No treatments or prescribing outcomes were evaluated. The article describes an assistive image-classification approach, not a replacement for definitive diagnostic assessment.

    Clinical Best Practices

    • Interpret the model as an assistive classification approach, consistent with the study’s stated intended use.

    Related Resources & Content

      Original Source(s)

      Related Content